Recent Developments in Ferulic Acid- and Caffeic Acid-Based Hybrids with Potential Anticancer Properties. [PDF]
Peter S, Sibali LL, Khwaza V, Paca AM.
europepmc +1 more source
Rational design of naphtho[2,3-<i>d</i>]imidazole-4,9-dione-linked 1,3,4-oxadiazoles as α-amylase inhibitors supported by QSAR, docking, molecular dynamics, and ADME approaches. [PDF]
Devi M +7 more
europepmc +1 more source
Novel pyrazole-oxadiazole-chalcone/oxime hybrids as dual EGFR/VEGFR-2 inhibitors with promising anticancer potential: a comprehensive cytotoxicity evaluation, mechanistic insights and SAR analysis. [PDF]
Alshazly O +3 more
europepmc +1 more source
Quinoline-Based Scaffolds in Anticancer Drug Discovery: Molecular Targets, Synthetic Strategies, and Biological Advances. [PDF]
Raza A, Wadhwa P, Sharma S.
europepmc +1 more source
Design, synthesis and antiproliferative, apoptotic, and immunomodulatory properties of new heteroaryl pyridine-linked 1,2,4-oxadiazoles as prospective dual EGFR/BRAF<sup>V600E</sup> inhibitors. [PDF]
Gomaa HAM +9 more
europepmc +1 more source
Bridging mechanism and design: modern medicinal chemistry approaches to thymidylate synthase inhibitors. [PDF]
Al-Karmalawy AA +4 more
europepmc +1 more source
Lonidamine-1,3,4-oxadiazole derivatives with antiproliferative effects on HCT116 colon cancer cell lines: biological evaluation, ADMET, and computational studies. [PDF]
Bhat RM +6 more
europepmc +1 more source
Design, synthesis and antiproliferative activity of oxadiazole derivatives as potent glycogen synthase kinase-3/histone deacetylase 6 dual inhibitors. [PDF]
Ye C +7 more
europepmc +1 more source
Exploring 1,3,4-oxadiazolyl sulfide derivatives as antidiabetic candidates: synthesis, antioxidant activity, SAR-study, molecular docking, and DFT-insights. [PDF]
Khalaf NA +3 more
europepmc +1 more source
Effect of 1,3,4-oxadiazoles on expression of biofilm-associated bap gene in clinical isolates of multidrug-resistant Acinetobacter baumannii. [PDF]
Rahimbakhsh A +5 more
europepmc +1 more source

